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Abstract
Background: During pregnancy, a sedentary lifestyle may have negative consequences on maternal and foetal
health status. The main objective of this project is to assess the effects of an exercise intervention in overweight
and grade I obese pregnant on maternal and foetal health markers.
Methods/design: The present study aims to recruit 60 overweight and grade I obese women interested in
participating in an exercise intervention program from the 17th gestational week until delivery. Women will be
randomized to either an exercise (three 60-min sessions/week of combined aerobic and strength training and
pelvic floor exercises), or usual care (control) group (30 women per group). The primary outcome measures are
maternal weight gain, and maternal and neonatal glycaemic profile. Secondary outcome measures are: i) perinatal
obstetric records; i) body composition; iii) dietary patterns; iv) physical fitness; v) low-back pain; vi) objectively
measured physical activity and sedentary behaviour; vii) haematology and biochemical analyses; viii) oxidative stress;
ix) pro- and anti-inflammatory markers; x) bone health biomarkers; xi) sleep quality; xii) mental health, quality of life
and positive health.
Discussion: The findings of this project will help to identify strategies for primary prevention and health promotion
based on this exercise-based intervention program among overweight and grade I obese pregnant women.
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Background
Assessing the influence of lifestyle during pregnancy on
maternal and foetal health is increasingly becoming a
matter of interest [1–3]. Among these behaviours, phys-
ical activity (PA) may play an important role [4–8]. The
sedentary lifestyle adopted by many pregnant women
predisposes them to obesity, hypertension or gestational
diabetes mellitus (GDM) [5, 6, 8], and the physiological
changes occurring during gestation magnify this risk [9].
Importantly, overweight or obesity during pregnancy is
associated with a significantly higher risk of pre-term de-
livery [10], birth-asphyxia-related complications [11],
pre-eclampsia, GDM, prolonged labour, caesarean sec-
tion, wound infection, postpartum haemorrhage, early
neonatal death or neonatal intensive care admission
[12–15], and infant mortality [16].
Maternal levels of PA may decline during pregnancy
likely as a result of the physical changes of pregnancy
and due to a combination of social and psychological
factors, such as the thinking that resting during preg-
nancy is the safest behaviour [17, 18]. However, increas-
ing PA levels during pregnancy is effective in the
prevention of GDM, hypertension, dysnea, excessive ges-
tational weight gain, and high birth weight, among
others [5, 7, 8, 19, 20]. Emerging evidence suggest that
exercise training during pregnancy (including moderate-
to-high intensity exercise) might provide beneficial ef-
fects on both maternal and foetal health without side ef-
fects [21, 22]. Indeed, it has been shown that exercise
during gestation prevents diastasis recti abdominis [23]
and that higher levels of strength or aerobic training are
positively associated with hospital stay length, incidence
of cesareans and Apgar test [24]. Further, strength train-
ing may reduce the need for insulin in overweight preg-
nant with GDM [25]. Finally, aerobic and strength
exercise improve physical fitness and result in additional
benefits [26, 27]. Moreover, during pregnancy, not only
the DNA of a new life is created, also programmed
through epigenetics. In this sense, maternal exercise may
have benefits on the newborn, such as higher neurodeve-
lopment [28, 29], better heart functioning, improved
heart rate variability [30] and less body fat [28]. How-
ever, it is unknown the extent to which supervised exer-
cise programs might improve inflammatory markers,
antioxidant activity or bone biomarkers. Moreover, most
of exercise programs conducted in pregnant women are
performed at light-to-moderate exercise intensity, or are
based on solely aerobic or strength training.
An optimal mental health during pregnancy is also a
major concern. High levels of depression or anxiety dur-
ing gestation and post-partum affect maternal quality of
life, and in turn, could have a negative influence on the
foetal and child health [31, 32]. Exercise may improve
the pregnant quality of life and reduce stress [33–36],
which might protect the foetus [31]. Also, adequate sleep
during gestation improves quality of life [37], prevents stress
and depression [38–40] and GDM [41, 42], reduces inflam-
matory signal [43] and the incidence of preeclampsia, pre-
mature birth or caesarea [44–46]. Further, optimal sleep in
pregnancy is essential for the foetal development [47] and a
better mother-child relationship [40]. However, pregnancy
frequently affects sleep quality [48, 49] and it would of clin-
ical relevance to better understand whether an exercise pro-
gram positively influences the pregnant sleep quality.
Therefore, the main objective of the GESTAtion and
FITness (GESTAFIT) project randomized controlled trial
(RCT) is to assess the effects of a novel supervised exer-
cise intervention developed in overweight and grade I
obese pregnant on maternal and foetal health.
The present methodological article describes the study
design, procedures and methods that will be conducted
in the “GESTAFIT project”.
Methods/design
Study design
A supervised RCT (registration number: NCT02582567)
based on an exercise program will be conducted in 60
overweight (body mass index (BMI) ≥ 25–29.9), or grade
I obese (BMI ≥ 30–34.9) pregnant women (n = 30 in the
exercise intervention group vs. 30 controls) from Gran-
ada (southeaster Spain). The organizational and partici-
pants flow is presented in Fig. 1.
The inclusion and exclusion criteria are described in
Table 1. Participants will have to provide a written in-
formed consent before taking part in the study, which will
be conducted in accordance with the CONSORT (Consol-
idated Standards of Reporting Trials) statement [50].
Moreover, women will have to answer “No” to all ques-
tions from the PARmed-X for pregnancy health checklist
(Physical Activity Readiness Medical Examination) by the
Canadian Society for Exercise Physiology [51].
This study was approved by the Clinical Research Ethics
Committee of Granada, Government of Andalusia, Spain
(code: GESFIT-0448-N-15). The study will be conducted
following the ethical guidelines of the Declaration of
Helsinki, last modified in 2013.
Recruitment process and measurements
procedures
The evaluation protocol scheme is shown in Table 2.
The measurements will be carried out in different days.
The first assessment day will coincide with the 12th ges-
tational week visit to the gynaecologist at “San Cecilio”
University Hospital, Granada, and potential participants
will be individually informed about the study objectives,
evaluation protocol and procedures. If the woman agrees
to participate in the present RCT, the researcher will
provide detailed information about each of the phases of
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the study, and the participant will be asked to read and
sign written informed consent. Subsequently (on the
same day), weight and height will be assessed. On the
second assessment day (16th gestational week) partici-
pants will attend the research centre and they will
complete the following assessments: nutritional and clin-
ical information, blood pressure, resting heart rate and
physical fitness. The initial survey (anamnesis) will be
conducted through face-to-face interviews by trained
staff in order to gather data on sociodemographic char-
acteristics, reproductive history, history of illness (hyper-
tension, diabetes, obesity, etc.), and diet. Other health
information will be collected using a self-administered
questionnaire and it will include personal questions re-
garding smoking and alcohol habits and indicators of
socio-demographic and socio-economic status (such as
personal and household income, educational level or
marital status). This survey will also include questions
regarding the employment of nutritional supplements or
special diets. Participant will then receive the accelerom-
eter and questionnaires to be completed there or at
home, and will be asked to return them eight days later.
Additionally, the Hospital will make an appointment
with the participants during that week for the biochem-
ical and urine samples collection. The third day of evalu-
ation will consist on accelerometry and sleep quality
assessment on the 24th week of gestation. The fourth
day of evaluation will take place on the 34th week of
gestation. This evaluation will be exactly the same to
that performed in the second day of evaluation before
the exercise program started (i.e. 16th gestational week),
including biochemical assessments.
Blood samples (5 mL) of all pregnant participants will
be extracted at week 16th and 34th of gestation, and at
delivery. Samples of venous and arterial blood from the
umbilical cord (5 + 5 mL) at the time of delivery will be
taken. In addition, samples of urine at 16 and 34 weeks
gestation and delivery will be collected. All samples will
be immediately frozen and conserved at −80 °C to avoid
breaking the cold chain before being sent to the
laboratory.
Sample size
The number of participants to be included in the study
was calculated on the basis of the change in body
weight. We used the difference in weight change ob-
served between the control and intervention group (1.04
Kg) in Ruiz et al. [20] as the expected effect size. A total
of 52 women (26 per group) will be needed to detect a
mean group difference of 1.04 and a standard deviation
of 1.15 Kg in weight change with a power of 90 % and α
of 0.05. However, we will exceed this sample size to
allow for withdrawals. Assuming a maximum lost-to-
Fig. 1 Organizational and participants flow
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follow up of 15 % [20], we will recruit a total of 30 par-
ticipants per group (n = 60).
Randomization and blinding
After all the baseline evaluations, participants will be ran-
domized to either the exercise intervention or the control
group. A computer generated simple randomization se-
quence will be created before participants will be enrolled,
to allocate participants to either group (1:1). The
randomization sequence will be prepared by a member of
the research team with no clinical involvement in the trial.
The allocation will be concealed in a password protected
computer file. Whereas the participants will be aware of
their group allocation, outcome assessors and data ana-
lysts will be blinded to the allocation.
Exercise intervention
Most of exercise programs developed for pregnant
women until now [20, 27, 52] have been designed in
compliance with the recommendations of the American
College of Obstetrics and Gynaecology (ACOG) in 2002
[53], or the Canadian Society for Exercise Physiology,
among others [54]. However, in 2011, Zavorsky & Longo
[55] launched a more actual, specific, and evidence-
based guideline for exercise programs during pregnancy.
Consequently, the exercise program that will be con-
ducted in the present project has been developed ac-
cordingly to this guideline [55]. Nonetheless, we have
also followed similar studies [56, 57] where aerobic and
resistance training, as well as strengthening of the pelvic
floor muscles [58], have been developed successfully and
in line with these recommendations [57].
The exercise intervention (n = 30) will be performed in
three groups of 10 participants and will meet the train-
ing standards of the American College of Sports Medi-
cine [59] for adults. The groups will train 3 days/week
(55–60 minutes per session) from the 17th week of ges-
tation until delivery. The exercise sessions will be de-
signed, carefully supervised, guided and instructed by
qualified exercise professionals with experience in work-
ing with pregnant women.
The exercise program planning is shown in Table 3. The
exercise intervention group will have different phases: a)
Information phase: which will involve the understanding
of the intervention plan for them, the goals we want to
work with them, and how we will perform it (one training
session); b) Movement Learning phase: theoretical and
practical sessions with the explanation of movements and
explanation of basic movement patterns (two training ses-
sions); and c) Physical Fitness Training phase: with train-
ing sessions aimed at improving fitness and weight
management (from the 18th until the 34th gestational
week), and training sessions focused on a correct pelvic
mobilization for the delivery (after the 34th gestational
week until delivery) in order to try to reduce caesarean
section rate, delivery time and number of pushes [23, 60].
The exercise intensity will be prescribed as percent-
ages of heart rate reserve (% HRR) [55] and the ratings
of perceived exertion (RPE) using the Borg 6–20 RPE
scale [61]. We will also employ the Karvonen formula to
estimate the training heart rate (e.g. 65 % HRR for a
pregnant with 185 bpm maximum heart rate and
80 bpm basal heart rate would be calculated as: Training
Heart Rate = 0.65 * (185–80) + 80). Heart rate will be
measured with heart rate monitors (Polar Electro OY,
Finland) to control the intensity of the sessions. One
third of the participants in the intervention group will
wear heart rate monitors in 1/3 of the sessions, both
randomly selected. Intensity (expressed as RPE) will be
expected to range from 12 to 16.
Table 1 Inclusion and exclusion criteria in the GESTAFIT project
Inclusion criteria
- Overweight or grade I obese pregnant woman aged 25–40 years
old with a normal pregnancy course.
- Answer “no” to all questions on the PARmed-X for pregnancy*.
- To be able to walk without assistance.
- To be able to read and write enough.
- Informed consent: To be capable and willing to provide consent.
*In addition, specific inclusion criteria for data analysis are: gestational
age at delivery of 37–42 weeks with single foetus, spontaneous
vaginal delivery or instrumental vaginal and caesarean without
maternofoetal pathology (or other indication that does not involve
maternofoetal risk, such as disproportion, failed induction, no foetal
progression or non-cephalic presentation), newborn with appropriate
weight, Apgar score > 7 in the 1st and 5th minute of life, cord blood
pH (normal > 7.20) and normal monitoring results.
Exclusion criteria
- Acute or terminal illness.
- Malnutrition.
- Inability to conduct tests for assessing physical fitness or exercise
during pregnancy.
- Underweight, normal-weight or grade II-III obesity.
- Pregnancy risk factors (such as hypertension, type 2 diabetes, etc.).
- Multiple pregnancies.
- Chromosopathy or foetal malformations.
- Uterine growth restriction.
- Foetal death.
- Upper or lower extremity fracture in the past 3 months.
- Presence of neuromuscular disease or drugs affecting
neuromuscular function
- Be registered in other exercise program
- Perform more than 300 min of at least moderate physical activity
per week
- Unwillingness to either complete the study requirements or to be
randomised into control or intervention group.
PARmed-X for pregnancy: Physical Activity Readiness Medical Examination
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The intensity will be adapted during the exercise pro-
gram based on the week of gestation and each woman’s
heart rate. The Physical Fitness Training phase sessions
until the 34th gestational week will consist of mixed
work, composed of circuits where both muscular and
cardiovascular conditioning will be implemented. This
type of exercise training has been already developed by
White et al. [57] who demonstrated better results for
both the prevention of GDM, preeclampsia and preterm
births, and for increased vaginal vs. caesarean deliveries.
Each training session will include 10 min warm-up
with walks, mobility and activation exercises. The main
part will consist of 40 min exercises organized in circuit.
The circuit will alternate muscular and cardiovascular
blocks of concurrent training. Each muscle circuit will
consist of a hip dominant movement exercise (e.g. dead-
lift exercises, hinge hip, swing hip), a dominant knee
(e.g. squats, lunges) 2 pull movements, 1 push move-
ment (push-ups adapted) and 1 CORE muscles move-
ment. Cardiovascular blocks will take approximately
3 min and will be composed of aerobic exercises as dif-
ferent variants of step-ups, small choreographies, front
and side trips. Sessions will finish with a 10 min cool-
down period of stretching, breathing, relaxation exer-
cises and myofascial relief [62]. None of the proposed
exercises will include Valsalva manoeuvre, supine posi-
tions, or high impact exercises that could go in detri-
ment of the successful activation of the lumbo-
abdominal belt, promote a decrease in venous return or
alterations in blood pressure, among others. The exer-
cise program volume and intensity programmed is also
shown in Table 3.
To maximize adherence, several strategies will be im-
plemented including music in all sessions and telephone
calls following missed sessions. The researchers will con-
trol and register the presence of adverse events during
the class and between classes.
The participants randomly assigned to the control
group (n = 30) will receive general advices about the
positive effects of PA during pregnancy for her and the
foetus’s health status. The researchers will give three
seminar explaining 1) the benefits of exercise for a better
pregnancy, prevention and treatment of GDM and ex-
cessive weight gain; 2) ergonomic advises, exercises to
perform at home (e.g. stretching, resistance training)
and strategies to increase their daily PA levels; 3) the














Clinical history X X X X
Weight and height X X X X
Body composition (dual-energy x-ray
absorptiometry)
X
Accelerometry X X X
Physical fitness X X
Nutritional study X X X
Questionnaires to be fill there or at home between the 1st and 2nd evaluation days
Low back-pain X X X
Quality of life X X X
Sleep quality X X X X
Physical activity X X X X
Self-perceived physical fitness X X X X
Sexual function X X X
Restless legs syndrome X X X
Mental and positive health X X X
2nd day evaluation: Accelerometers collection and
review of questionnaires
X X
Maternal biochemical analysis X X X
Umbilical cord blood sampling X
Maternal urine sampling X X X
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Joint mobility and different walk modalities
CONDITIONING
40 min
Training week 1 2–4 5–6 7–8 9–10 11–12 13–14 15–16 17–18 >19
Gestational week 17 18–20 21–22 23–24 25–26 27–28 29–30 31–32 33–34 >34
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acquisition of the basic
movement patterns
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Myofascial release, stretching and relaxation exercises














benefits of the Mediterranean Diet and nutritional edu-
cation. Moreover, we will prepare brochures describing
the overall benefits of PA on health, and we will dispense
general guidelines to increase the level of daily PA and
optimum nutrition during pregnancy [63, 64].
Primary and secondary outcomes
Primary outcome
The primary outcomes are maternal weight gain and
maternal and foetal glycaemic profile. Maternal weight
gain will be defined as the weight change from baseline
measurement to the last measurement at 34th week of
gestation. Maternal insulin sensitivity will be derived
from the homeostatic model assessment for insulin
resistance (HOMA-IR), which will be calculated using
the formula [fasting insulin (μIU/mL) × fasting glu-
cose (mg/dL)]/405 in the 34th week of gestation.
Neonatal insulin sensitivity will be assessed through
the cord blood ratio glucose/insulin.
Secondary outcomes
Maternal and foetal outcomes
Birth weight; gestational age; type of delivery (natural,
instrumental, or caesarean); Apgar scores (at 1 and
5 min); time of dilation, expulsion, and childbirth; GDM;
and hypertension, will be obtained from perinatal obstet-
ric records.
Blood pressure and resting heart rate
Systolic and diastolic blood pressure, as well as resting
heart rate, will be measured after 5 min of rest, on 2 sep-
arate occasions (with 2 min between trials), with the per-
son seated (Omron Health Care Europe B.V.
Hoolddorp). The lowest value of the two trials will be se-
lected for the analysis.
Maternal and foetal anthropometry and body composition
Maternal Height will be measured only at the baseline
measurement with a stadiometer (Seca 22, Hamburg).
Pre-pregnancy weight will be based on self-report.
Height measurement and pre-pregnancy weight will be
used to calculate BMI (weight[Kg]/height[m2]) [65].
One month after delivery (postpartum period) lean, fat
and bone mass of the whole body will be measured
using a dual-energy x-ray absorptiometry (DXA) device
(Hologic Discovery QDR, Nasdaq: HOLX). Waist cir-
cumference (cm) will be assessed at the middle point be-
tween the ribs and the ileac crest, with the participant
standing (Harpenden anthropometric tape, Holtain Ltd).
Foetus/newborn A monitoring of the evolution of the
foetal anthropometrics will be performed by obstetrical
ultrasound measurements following the standards of the
International Society of Ultrasound in Obstetrics and
Gynaecology guidelines and the methodology by Perin et
al. [66]. The baby also will have a physical examination
within 24 h after birth. Baby’s weight, length and head
circumference will be measured. Newborns will be clas-
sified as having low birth weight or macrosomia when
birth weight was less than 2500 g and greater than
4000 g, respectively.
Dietary patterns
The Mediterranean Diet Score [67] in a version adapted
to the specific needs during pregnancy for Fe, Ca and
folic acid [68] will be used to assess the adherence to the
traditional Mediterranean dietary pattern. A moderate
alcohol diet, also typical of the Mediterranean Diet, will
not be considered for calculating the index in this group
of women, who should not drink alcohol due to their
pregnancy.
The frequency of consumption of foods will be also
studied by means of a quantitative questionnaire, vali-
dated and designed by Mataix et al. [69].
Physical fitness
Participants’ physical fitness status in the 16th and 34th
week of pregnancy will be assessed by means of the fol-
lowing tests:
Cardiorespiratory fitness Aerobic capacity will be esti-
mated with a submaximal cycle ergometer heart rate
method. A pedaling rate of 50 rpm will kept constant by
use of a metronome. Initial workload, 50 W or 75 W,
will be based on the women’s reported physical activity
levels, and increased by 25 W per minute until a steady
state heart rate of 125 · beats or more · per minute was
reached, after which the women will cycle for at least
6 min until two consecutive heart rates, one minute
apart, differ by 3 or fewer beats · per minute. The
VO2max will be calculated according to the Åstrand and
Ryhming nomogram [70].
We will additionally perform the 6-min walk test,
which measures the maximum distance (in meters) each
participant can walk in 6 min along a 45.7 m rectangular
course [71].
Upper-body muscle strength The handgrip strength
will be measured using a digital dynamometer (TKK
5101 Grip-D; Takey, Tokyo, Japan) as described else-
where [72]. The participants will perform (alternately
with both hands) these tests twice. The best value of 2
trials for each hand will be chosen and the average of
both hands will be used in the analyses.
Upper-body flexibility The back-scratch test, a measure
of overall shoulder range of motion, involves measuring
the distance between (or overlap of ) the middle fingers
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behind the back with a ruler [71]. The best score of two
attempts for each arm in centimetres will be recorded
and the average of both arms will be used in the
analyses.
Self-perceived physical fitness The International Fit-
ness Scale [73] is composed of five Likert-scale questions
asking about the perceived participants’ overall fitness,
cardio-respiratory fitness, muscular fitness, speed-agility
and flexibility in comparison with their friends’ physical
fitness (“very poor”, “poor”, “average”, “good” and “very
good”).
Low-back pain
Pregnant women usually report low-back pain, especially
in the third gestational trimester. Low-back pain will be
assessed with the Spanish version of the Oswestry Dis-
ability Index score [74]. We will additionally employ the
Pain Visual Analogue Scale to assess low back pain in-
tensity [75].
Physical activity and sedentary behaviour
Accelerometry will be used to objectively assess PA and
sedentary time. Women will be asked to wear a tri-axial
accelerometer (ActiSleep+, Pensacola, Florida, United
States) for 9 consecutive days, starting the same day they
receive the monitor (e.g. participants who receive the ac-
celerometer on Monday, will carry the device until Tues-
day of the next week). The first and last day will be
excluded from the analyses, accounting for a total of
7 days of registering. Participants will be instructed to
wear the accelerometer during the whole day (24 h) on
their wrist attached by an elastic belt. To prevent any
damage to the devices, these will be taken off during
water-based activities such as bathing or swimming.
Time engaged in light, moderate, and moderate-vigorous
intensity PA and sedentary time will be calculated. This
accelerometer has been previously used in pregnancy
with similar methodology as described in the present
protocol [19].
Haematology and biochemical analysis
Venous blood samples will be extracted in standardized
fasting conditions at 8–9 a.m. in the hospital and col-
lected in EDTA vacuum tubes, and tubes for serum.
Some samples will be centrifuged at 1750 rpm for
10 min at 4 °C in a refrigerated centrifuge (GS-6R Beck-
man, Fullerton, CA, USA) to separate plasma from
formed elements. Subsequently, erythrocytes will be cen-
trifuged in a hypertonic solution to remove membranes
and cytosol.
Haematology Erythrocyte count, haematocrit, haemo-
globin, platelets, leukocytes and erythrocyte mean cor-
puscular volume will be quantified by a Coulter counter.
Biochemical parameters Plasma total, high-density
lipoprotein and low-density lipoprotein cholesterol, tri-
glycerides, phospholipids, creatine kinase, aspartate ami-
notransferase, alanine aminotransferase, gamma-
glutamyl transferase, lactate dehydrogenase, alkaline
phosphatase, glucose, urea, insulin, albumin, high sensi-
tivity C-reactive protein, glycosylated haemoglobin, cre-
atinine, total bilirubin, myoglobin, lactate, troponin I,
peroxisome proliferator-activated receptor-γ coactivator
(PGC)-1α, nitric oxide and myeloperoxidase will be
assessed with standard methods using an autoanalyzer
(Hitachi-Roche p800, F. Hoffmann-La Roche Ltd.




– Plasma measurements: liposoluble antioxidants
(vitamin E, retinol, carotene, coenzyme Q10 and
coenzyme Q9) through mass spectrometry and the
total plasma antioxidant capacity by using
commercial kit (spectrophotometry).
– Erythrocyte measurements: liposoluble antioxidants
in membrane (vitamin E and coenzyme Q10)
through mass spectrometry and antioxidant
enzymes activity (catalase, glutathione peroxidase
and superoxide dismutase) by spectrophotometry.
b) Oxidative damage
– Oxidative damage to proteins: measurement of
carbonyl proteins by using commercial kit
(spectrophotometry).
– Oxidative damage to lipids: measurement of 4-
hydroxynonenal and isoprostanes in urine and
plasma and hydroperoxides in plasma and erythro-
cyte membrane by using commercial kits (spectro-
photometry and ELISA).
– Oxidative damage to DNA: measurement of 8-
hydroxyguanosine in urine and plasma by commer-
cial kits (ELISA).
Pro- and anti-inflammatory signal
Some maternal and umbilical cord plasma pro-
inflammatory and anti-inflammatory cytokines (IL-1β,
IL-2, IL-6, IL-8, IL-10, IFN-γ and TNF-α, IL-1ra and
TNF Srii α), some adipokines (adiponectin, adipsin,
resistin, PAI-active, insulin and leptin) and myokines
(irisin) will be measured by the employment of Luminex
xMAP technology.
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Bone biomarkers
Various relevant biomarkers related to bone metabolism
(ACTH, DKK-1, FGF-23, Osteocalcin, OPN-Osteopontin,
Osteoprotegerin, PTH and SOST) will be measured with
Luminex xMAP technology.
Sleep quality
The Pittsburgh Sleep Quality Index [76] will be used to
assess sleep quality and disturbances over a l-month
time interval. Nineteen individual items generate seven
“component” scores: subjective sleep quality, sleep la-
tency, sleep duration, habitual sleep efficiency, sleep dis-
turbances, use of sleeping medication, and daytime
dysfunction. Each component yields a score ranging
from 0 to 3, with 3 indicating the greatest dysfunction.
The seven component scores are summed to provide a
global sleep quality score (range 0 to 21) with higher
scores indicating poor sleep quality.
Nevertheless, it has been shown that reported sleep by
pregnant women varies in relation to that objectively es-
timated with accelerometry [77]. Consequently, behav-
iours related to sleep, such as sleep onset, sleep latency,
total sleep time, number and duration of awakenings
and sleep efficiency will be objectively calculated by
using a triaxial accelerometer (ActiSleep+, Pensacola,
Florida, United States). The data analysis of such Acti-
Sleep accelerometry data will be carried out through its
specific software (Actilife).
Quality of life, mental health and positive health
We will use the Short-Form Health Survey 36 [78], for
assessing health-related quality of life. It contains 36
items grouped into 8 dimensions: physical functioning,
physical role, body pain, general health, vitality, social
functioning, emotional role, and mental health. The
scores range from 0 to 100 in every dimension, where
higher scores indicate better health.
The pregnant antenatal depression will be assessed
with the Center for Epidemiological Studies-Depression
Scale questionnaire [79], which is validated and widely
employed in pregnancy. Postnatal depression levels will
be assessed with the Spanish version of the Edinburgh
Postnatal Depression Scale [80], which is a 10-items self-
report scale designed as a specific instrument to detect
postnatal depression.
Anxiety levels will be assessed with the State Trait
Anxiety Index [81]. This questionnaire consists of two
scales that assess anxiety state and trait anxiety. The
total score ranges from 20 to 80, with higher values indi-
cating higher levels of anxiety.
The “Restless Legs Syndrome” largely determines the
quality of life for many pregnant and is related to their
levels of depression and sleep quality [82]. The Spanish
version of the Detention of Restless Legs Syndrome
questionnaire [83] will be employed to assess the pres-
ence and severity of this syndrome.
Sexual function is also an important aspect of the
quality of life of a person. The Spanish version of the 6-
item Female Sexual Function Index [84] was used to as-
sess sex function. This instrument is composed of six
questions: desire, arousal, lubrication, orgasm, satisfac-
tion and pain. Each question can be scored from 0 to 5
and then summed up to provide a total score.
Finally, “positive health” will be evaluated through the
following questionnaires:
1) The Trait Meta-Mood Scale [85] is comprised of 3
subscales to assess participant’s beliefs about
attending to and value their feelings (emotional
attention), feel clear rather than confused about
their feelings (emotional clarity) and how well
participants regulate their moods and repair negative
emotional experiences (emotional repair). Each
subscale comprises 8 items. Participants rate their
responses using a 5-point Likert type scale, with 1
= “strongly disagree” to 5 = “strongly agree”. The
subscales score range from 8 to 40 and higher scores
reflect greater attention, clarity, and repair.
2) The Positive and Negative Affect Schedule [86] is a
20-item questionnaire designed to measure positive
and negative affect. The questionnaire includes 10
positive and 10 negative emotional states that should
be answered on a 5-point Likert scale, from 1 = “very
slightly or not at all” to 5 = “extremely”. The score
ranges from 10 to 50 for both subscales (positive
affect and negative affect), and higher scores reflect
greater affective well-being.
3) The 10-item Connor-Davidson Resilience Scale [87,
88] assesses resilience to stress, which is a construct
refers to a dynamic process of positive adaptation to
adverse changes in life circumstances. Each item
ranges from 0 = “not true at all” to 4 = “true nearly
all the time”. The total score range from 0 to 40, and
higher scores indicate greater resilience.
Statistical analysis
Since this study aims at determining potential biological
effects of exercise, the statistical analysis will be per-
formed on a per-protocol basis, thus, including in the
analyses only participants who attended at least 80 % the
exercise session and completed both baseline and
follow-up evaluations. The treatment effects will be re-
ported as between-group changes on the primary and
secondary outcomes and will be assessed with general-
ized linear models after adjusting for baseline values. All
the analyses will be repeated additionally adjusting for
age and any other confounder potentially not well bal-
anced at baseline, and the results from both models will
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be reported. The effect size (95 % confidence interval)
and statistical significance will be reported for each
study outcome. The statistical significance will be set at
α = 0.05. Sensitivity analyses will be conducted using
intention-to-treat analyses and baseline observation car-
ried forward imputation.
Discussion
This paper describes the protocol performed by a multi-
disciplinary team of experts in PA and exercise, nutri-
tion, gynaecology and physiology that aims to determine
the effects of a supervised exercise intervention devel-
oped in overweight and grade I obese pregnant on the
mother and newborn health, and the influence of life-
style during pregnancy on relevant, but no explored yet,
maternal and foetal outcomes.
The intrauterine environment seems to be involved in
programming and foetal offspring exposed to maternal
stress, inappropriate diet, physical inactivity, obesity or
hyperglycaemia, among others, may be prone to future
metabolic alterations and chronic diseases [26, 89–91].
Among these modifiable behaviours, PA is especially
relevant during gestation [4–6]. Increasing PA levels or
exercising during pregnancy is an efficient tool to tackle
cardiometabolic diseases such as GDM, and excessive
maternal and neonatal weight gains [5, 19, 92]. However,
modern society sometimes treats pregnancy as a disease.
For example, it qualifies as vulnerable women and are ex-
cluded from most studies [93]. Furthermore, is noticeably
that most of the interventions focus on improving pregnant
health involve mere advices or counselling given face to
face, or by phone (or both). Just few trials have investigated
well-controlled individually tailored exercise interventions.
Consequently, further trials, with objective outcome mea-
sures, are needed. Moreover, the influence of physical
fitness on important maternal health markers during gesta-
tion, such as quality of life, positive health, inflammatory
profile, bone health, or oxidative stress is unknown.
Exercise during pregnancy is safe [21, 22] and side-
effects are minimal [53, 54] if pregnant adequate the in-
tensity of such exercise to warrant foetal wellbeing [94].
However, the exercise intensity suggested by the ACOG
in 2002 [53] and by Davenport et al. [95] will not be
adopted in the present RCT. This is firstly, because the
minimum work intensity is stated at 101 bpm for all
women (which constitute a low heart rate), and sec-
ondly, because they make an absolute estimation (inde-
pendently of the woman’s age, basal heart rate, or
physical fitness status). Thereby, in agreement with
Zavorsky & Longo [55], we advocate for modulating the
intensity based on the % HRR, and the RPE.
Not less important for an optimal pregnancy is a
healthy psychological status [31, 32, 96]. In that sense,
exercise represent an excellent opportunity to improve
quality of life [33] and reduce cortisol levels, which may
in turn have a positively influence on the foetus and
child [31, 32]. Besides, it is unknown whether exercise
could positively influence the characteristic worse sleep
quality during gestation [48, 49], which can alter the
pregnant metabolic status [41–43] and gestational out-
comes [44–46] and negatively affect the pregnant quality
of life [37–40] and the foetal development [47].
There is a clear and compelling rationale for increased
pregnancy research in order to address the therapeutic
needs of pregnant women [93]. Additionally, there is ac-
cumulating evidence that pregnancy provides a unique
window into understanding fundamental mechanisms
underlying observed links between a pregnant woman’s
health and her later health and the health of her children
[93]. The information obtained from this RCT will there-
fore be of clinical and public health interest and will sug-
gest future research. Further, the exercise intervention
designed is novel and non-expensive, and can be easily
transferred to other similar contexts. Consequently, the
findings of the GESTAFIT Project will help the Health
Systems to identify strategies for primary prevention and
health promotion among overweight and obese pregnant.
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